Insulin Delivery Devices Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (External/Tethered, Patch), Pen Needles (Standard, Safety), Insulin Syringes) and End User (Patients/Homecare, Hospitals & Clinics) - Global Forecast to 2021

  • ID: 4225632
  • Report
  • Region: Global
  • 151 Pages
  • Markets and Markets
1 of 5
The Insulin Delivery Devices Market is Projected to Reach USD 17.85 Billion By 2021 from USD 11.54 Billion in 2016, Growing at a CAGR of 9.1% in the Next Five Years (2016 to 2021)

FEATURED COMPANIES

  • Biocon Limited
  • Eli Lilly And Company
  • Insulet Corporation
  • Medtronic Plc
  • Novo Nordisk A/S
  • Sanofi
  • MORE

Favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, growing diabetic population, and rising awareness about insulin delivery devices are the major factors driving the growth of this market. However, needle anxiety, emergence of oral drug delivery methods, and the growing trend of reuse of pen needles and infusion sets are the major factors restraining the growth of this market. Furthermore, increasing research and development activities and increasing diabetes-related health expenditure in emerging countries are likely to offer significant growth opportunities for players operating in the market.

The global insulin delivery devices market is segmented on the basis of type, end user, and region. In 2016, North America accounted for the largest share of the market, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region is projected to have the highest growth rate in the forecast period. Factors such as rising prevalence of diabetes, high adoption of insulin pens, and government initiatives in Singapore are expected to support the growth of the Asia-Pacific insulin delivery devices market.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, collaborations, agreements, partnerships, alliances, grants, joint ventures, acquisitions, and expansions) to increase their market shares and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the insulin delivery devices market.

  • By Company Type: Tier 1: 70%, Tier 2: 22%, Tier 3: 8%
  • By Designation: Director Level: 65%, C-level: 25%, Others: 10%
  • By Region: North America: 55%, Europe: 20%, APAC: 20%, RoW: 5%

Research Coverage:
This report studies the insulin delivery devices market based on type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one, or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the types of insulin delivery devices offered by top players in the insulin delivery devices market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the insulin delivery devices market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for insulin delivery devices across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the insulin delivery devices market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the insulin delivery devices market
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Biocon Limited
  • Eli Lilly And Company
  • Insulet Corporation
  • Medtronic Plc
  • Novo Nordisk A/S
  • Sanofi
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Insulin Delivery Devices: Market Snapshot
4.2 Geographic Analysis: Market, By Type (2016)
4.3 Insulin Delivery Devices Market Size, By End User, 2016 vs 2021 (USD Billion)
4.4 Geographic Snapshot of the Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Diabetic Population
5.2.1.2 Technological Advancements in Insulin Delivery Devices
5.2.1.3 Favorable Reimbursement Environment and Government Support in Selected Countries
5.2.1.4 Conferences, Meetings, and Congresses to Create Awareness About Insulin Delivery Devices
5.2.2 Restraints
5.2.2.1 Poor Reimbursement Structure in Developing Countries
5.2.2.2 Needle Anxiety in Patients to Affect the Growth of the Pen Needles and Syringes Market
5.2.2.3 Oral Insulin as an Alternative Drug Delivery Method
5.2.2.4 Issues Associated With the Reuse of Pen Needles and Infusion Sets
5.2.3 Opportunities
5.2.3.1 Increasing Research and Development Activities
5.2.3.2 Increasing Diabetes-Related Health Expenditure in Emerging Economies
5.2.3.3 Safety Needles
5.2.4 Challenge
5.2.4.1 Severe Shortage of Endocrinologists in the U.S.

6 Insulin Delivery Devices Market, By Type
6.1 Introduction
6.2 Pens
6.2.1 Reusable Insulin Pens
6.2.2 Disposable Insulin Pens
6.3 Insulin Pumps
6.3.1 External/Tethered Pumps
6.3.2 Patch Pumps
6.4 Pen Needles
6.4.1 Standard Pen Needles
6.4.2 Safety Pen Needles
6.5 Insulin Syringes
6.6 Other Insulin Delivery Devices

7 Insulin Delivery Devices Market, By End User
7.1 Introduction
7.2 Patients/Homecare
7.3 Hospitals & Clinics

8 Insulin Delivery Devices Market, By Region
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.1.1 Rising Prevalence of Diabetes and Favorable Reimbursement Scenario
8.2.1.2 Awareness Activities to Stimulate Usage of Insulin Delivery Devices in the U.S.
8.2.1.3 Growing Venture Capital Investments and Issuance of Ipos
8.2.1.4 FDA Approvals to Increase the Commercial Availability of Insulin Delivery Devices
8.2.2 Canada
8.2.2.1 High Prevalence of Diabetes and Favorable Reimbursement for Insulin Delivery Devices
8.2.2.2 Regulations for the Usage of Safety-Engineered Needles
8.3 Europe
8.3.1 Eu’s Directive on the Prevention of Sharps Injuries in Hospitals and the Healthcare Sector
8.3.2 Germany
8.3.2.1 High Prevalence of Diabetes, Favorable Reimbursement for Insulin Devices
8.3.3 France
8.3.3.1 High Insurance Coverage and Increasing Affordability
8.3.3.2 Conferences and Exhibitions
8.3.4 U.K.
8.3.4.1 Role of Diabetes U.K. in Research and Diabetes Care
8.3.4.2 Low Insulin Pump Penetration in the U.K.
8.3.5 Rest of Europe (RoE)
8.3.5.1 Spain: Regulations for Mandatory Use of Safety Needles, Large Diabetic Population
8.3.5.2 Italy: Regional Variations in Terms of Coverage and Benefits to Hinder Market Growth
8.3.5.3 Strong Presence of Major Insulin Delivery Device Manufacturers in RoE Countries
8.3.5.4 Large Diabetic Populations in Russia, Romania, Poland, and Portugal
8.4 Asia- Pacific
8.4.1 High Diabetes Incidence and Population in Asia-Pacific
8.4.2 Partnerships Among Global and Local Players in Asia-Pacific
8.4.3 Japan: High Adoption of Insulin Pens and Approval of Injectable Insulin
8.4.4 India: Low Penetration of Pen Needles & Pumps and Low Awareness to Restrain Market Growth
8.4.5 Government Initiatives in Singapore
8.4.6 Vietnam, A Potential Market for Insulin Delivery Devices
8.4.7 Australia: Amendments in Ndss to Broaden Patient Access to Diabetes Products
8.5 RoW
8.5.1 Increasing Diabetic Population
8.5.2 Rising Awareness on Diabetes
8.5.3 Conferences

9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis
9.3 Competitive Situation and Trends
9.3.1 Marketing and Promotion
9.3.2 Agreements, Alliances, Partnerships, Joint Ventures, and Collaborations
9.3.3 Product Launches
9.3.4 Expansions
9.3.5 Other Strategies

10 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
10.1 Introduction
10.2 Becton, Dickinson and Company
10.3 Novo Nordisk A/S
10.4 Medtronic PLC
10.5 Sanofi
10.6 ELI Lilly and Company
10.7 Ypsomed Holding AG
10.8 Animas Corporation (Johnson and Johnson)
10.9 Tandem Diabetes Care, Inc.
10.10 Insulet Corporation
10.11 Biocon Limited

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

11 Appendix
11.1 Discussion Guide
11.2 Other Developments
11.3 Knowledge Store
11.4 Introducing RT: Real-Time Market Intelligence
11.5 Available Customizations
11.6 Related Reports
11.7 Author Details

List of Tables

Table 1 10 Countries/Territories With the Highest Number of Diabetics (20–79 Years), 2015 & 2040
Table 2 FDA Approvals in the Insulin Delivery Devices Market (2014–2016)
Table 3 Conferences, Meetings, and Congresses Focusing on Insulin Delivery Devices (2014–2017)
Table 4 Global Market Size, By Type, 2014–2021 (USD Million)
Table 5 Global Market Size, By Type, 2014–2021 (Thousand Units)
Table 6 Pens Market Size, By Type, 2014–2021 (USD Million)
Table 7 Pens Market Size, By Type, 2014–2021 (Thousand Units)
Table 8 Pens Market Size, By Region, 2014–2021 (USD Million)
Table 9 Pens Market Size, By Region, 2014–2021 (Thousand Units)
Table 10 Reusable Insulin Pens Market Size, By Region, 2014–2021 (USD Million)
Table 11 Reusable Insulin Pens Market Size, By Region, 2014–2021 (Thousand Units)
Table 12 Disposable Insulin Pens Market Size, By Region, 2014–2021 (USD Million)
Table 13 Disposable Insulin Pens Market Size, By Region, 2014–2021 (Thousand Units)
Table 14 Insulin Pumps Market Size, By Type, 2014–2021 (USD Million)
Table 15 Insulin Pumps Market Size, By Type, 2014–2021 (Thousand Units)
Table 16 Insulin Pumps Market Size, By Region, 2014–2021 (USD Million)
Table 17 Insulin Pumps Market Size, By Region, 2014–2021 (Thousand Units)
Table 18 External/Tethered Pumps Market Size, By Region, 2014–2021 (USD Million)
Table 19 External/Tethered Pumps Market Size, By Region, 2014–2021 (Thousand Units)
Table 20 Patch Pumps Market Size, By Region, 2014–2021 (USD Million)
Table 21 Patch Pumps Market Size, By Region, 2014–2021 (Thousand Units)
Table 22 Pen Needles Market Size, By Type, 2014–2021 (USD Million)
Table 23 Pen Needles Market Size, By Type, 2014–2021 (Thousand Units)
Table 24 Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 25 Pen Needles Market Size, By Region, 2014–2021 (Thousand Units)
Table 26 Standard Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 27 Standard Pen Needles Market Size, By Region, 2014–2021 (Thousand Units)
Table 28 Safety Pen Needles Market Size, By Region, 2014–2021 (USD Million)
Table 29 Safety Pen Needles Market Size, By Region, 2014–2021 (Thousand Units)
Table 30 Insulin Syringes Market Size, By Region, 2014–2021 (USD Million)
Table 31 Insulin Syringes Market Size, By Region, 2014–2021 (Thousand Units)
Table 32 Other IDD Market Size, By Region, 2014–2021 (USD Million)
Table 33 Other IDD Market Size, By Region, 2014–2021 (Thousand Units)
Table 34 Market Size, By End User, 2014-2021 (USD Million)
Table 35 Patients/Homecare Market Size, By Region, 2014-2021 (USD Million)
Table 36 Hospitals & Clinics Market Size, By Region, 2014-2021 (USD Million)
Table 37 Market Size, By Region, 2014-2021 (USD Million)
Table 38 North America: Insulin Delivery Devices Market Size, By Country, 2014-2021 (USD Million)
Table 39 North America: Market Size, By Type, 2014-2021 (USD Million)
Table 40 North America: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 41 North America: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 42 North America: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 43 North America: Insulin Delivery Devices Market Size, By End User, 2014-2021 (USD Million)
Table 44 Investements Made By Companies for Diabetes Management, 2015
Table 45 FDA Approvals for Insulin Delivery Devices (2013-2016)
Table 46 U.S.: Market Size, By Type, 2014-2021 (USD Million)
Table 47 U.S.: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 48 U.S.: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 49 U.S.: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 50 U.S.: Insulin Delivery Devices Market Size, By End User, 2014-2021 (USD Million)
Table 51 Eligibility for Insulin Pumps and Supplies in Canada for Type I Diabetes, March 2015
Table 52 Canada: Insulin Delivery Devices Market Size, By Type, 2014-2021 (USD Million)
Table 53 Canada: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 54 Canada: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 55 Canada: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 56 Canada: Market Size, By End User, 2014-2021 (USD Million)
Table 57 Europe: Market Size, By Country, 2014-2021 (USD Million)
Table 58 Europe: Market Size, By Type, 2014-2021 (USD Million)
Table 59 Europe: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 60 Europe: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 61 Europe: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 62 Europe: Market Size, By End User, 2014-2021 (USD Million)
Table 63 Germany: IDD Market Size, By Type, 2014-2021 (USD Million)
Table 64 Germany: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 65 Germany: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 66 Germany: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 67 Germany: Market Size, By End User, 2014-2021 (USD Million)
Table 68 France: Insulin Delivery Devices Market Size, By Type, 2014-2021 (USD Million)
Table 69 France: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 70 France: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 71 France: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 72 France: Insulin Delivery Devices Market Size, By End User, 2014-2021 (USD Million)
Table 73 U.K.: Market Size, By Type, 2014-2021 (USD Million)
Table 74 U.K.: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 75 U.K.: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 76 U.K.: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 77 U.K.: Insulin Delivery Devices Market Size, By End User, 2014-2021 (USD Million)
Table 78 Indicative List: Companies Headquartered in RoE Countries
Table 79 RoE: Market Size, By Type, 2014-2021 (USD Million)
Table 80 RoE: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 81 RoE: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 82 RoE: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 83 RoE: Insulin Delivery Devices Market Size, By End User, 2014-2021 (USD Million)
Table 84 Diabetes Prevalence in Asia-Pacific, By Country
Table 85 Asia-Pacific: Market Size, By Type, 2014-2021 (USD Million)
Table 86 Asia-Pacific: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 87 Asia-Pacific: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 88 Asia-Pacific: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 89 Asia-Pacific: Insulin Delivery Devices Market Size, By End User, 2014-2021 (USD Million)
Table 90 Conference in Africa, Brazil, and the Middle East (2015-2017)
Table 91 RoW: Insulin Delivery Devices Market Size, By Type, 2014-2021 (USD Million)
Table 92 RoW: Insulin Pens Market Size, By Type, 2014-2021 (USD Million)
Table 93 RoW: Insulin Pumps Market Size, By Type, 2014-2021 (USD Million)
Table 94 RoW: Pen Needles Market Size, By Type, 2014-2021 (USD Million)
Table 95 RoW: Market Size, By End User, 2014-2021 (USD Million)
Table 96 Marketing and Promotion: Recent Developments (2014–2017)
Table 97 Agreements, Alliances, Partnerships, Joint Ventures, and Collaborations: Recent Developments (2014–2017)
Table 98 Product Launches: Recent Developments (2014–2017)
Table 99 Expansions: Recent Developments (2014–2017)
Table 100 Other Strategies: Recent Developments (2014–2017)

List of Figures

Figure 1 Global Insulin Delivery Devices Market: Research Methodology Steps
Figure 2 Market Size Estimation Methodology: Bottom-Up Approach
Figure 3 Market Size Estimation Methodology: Top-Down Approach
Figure 4 Research Design
Figure 5 Data Triangulation Methodology
Figure 6 Insulin Pens Segment Commanded the Largest Share of the Insulin Delivery Devices Market in 2016
Figure 7 Patients/Homecare Segment to Register the Highest CAGR in the Forecast Period
Figure 8 North America Commanded the Largest Share of the Insulin Delivery Devices Market in 2016
Figure 9 Asia-Pacific Offers Significant Growth Opportunities for Players in the Insulin Delivery Devices Market
Figure 10 Insulin Pens Accounted for the Largest Market Share in 2016
Figure 11 Patients/Homecare Segment Accounted for the Largest Share of the Insulin Delivery Devices Market in 2016
Figure 12 Asia-Pacific to Register the Highest Growth Rate in the Forecast Period (2016–2021)
Figure 13 Insulin Delivery Devices Market: Drivers, Restraints, Opportunities, and Challenges
Figure 14 Pens Commanded the Largest Share in Insulin Delivery Devices Market in 2016
Figure 15 Patients/Homecare Segment to Command the Largest Share of the Insulin Delivery Devices End-User Market
Figure 16 North America: Insulin Delivery Devices Market Snapshot
Figure 17 Europe: Market Snapshot
Figure 18 Diabetes U.K.: Funds Raised vs Funds Invested
Figure 19 Comparison of Diabetes Cases, Related Deaths in European Countries, 2015
Figure 20 Asia-Pacific Market Snapshot
Figure 21 RoW Insulin Delivery Devices Market Snapshot
Figure 22 Growth Strategies, By Company
Figure 23 Market Share Analysis for Insulin Pens, By Key Player, 2016
Figure 24 Market Share Analysis for Insulin Pumps, By Key Player, 2016
Figure 25 Market Share Analysis for Pen Needles, By Key Player, 2016
Figure 26 Market Share Analysis for Syringes, By Key Player, 2016
Figure 27 Companies Adopted Marketing & Promotion as Key Growth Strategy From 2013 to 2016
Figure 28 Geographic Assessment of Players in the Insulin Delivery Devices Market
Figure 29 Becton, Dickinson and Company: Company Snapshot (2016)
Figure 30 Novo Nordisk A/S: Company Snapshot (2016)
Figure 31 Medtronic PLC: Company Snapshot (2016)
Figure 32 Sanofi: Company Snapshot (2016)
Figure 33 ELI Lilly and Company: Company Snapshot (2015)
Figure 34 Ypsomed Holding AG: Company Snapshot (2015)
Figure 35 Johnson and Johnson: Company Snapshot (2016)
Figure 36 Tandem Diabetes Care, Inc.: Company Snapshot (2015)
Figure 37 Insulet Corporation: Company Snapshot (2015)
Figure 38 Biocon, Ltd.: Company Snapshot (2015)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Biocon Limited
  • Eli Lilly And Company
  • Insulet Corporation
  • Medtronic Plc
  • Novo Nordisk A/S
  • Sanofi
  • MORE

The insulin delivery devices market is projected to reach USD 17.85 Billion by 2021 from 11.54 Billion in 2016, growing at a CAGR of 9.1% during the forecast period. The major drivers in the market include favorable reimbursement scenario and government support in selected countries, technological advancements in insulin delivery devices, and growing diabetic population.

The global insulin delivery devices market is categorized on the basis of type, end user, and region. On the basis of type, the market is categorized into pens, pumps, pen needles, syringes, and other devices (jet injectors, transdermal patches, and inhalers). In 2016, the insulin pens segment accounted for the largest share of the global insulin delivery devices market. The insulin pens segment is further divided into reusable pens and disposable pens. In 2016, the reusable segment commanded the largest share of insulin pens market. The pumps segment is further segmented into external/ tethered pumps and patch pumps. In 2016, the external/tethered pumps segment accounted for the largest share of the insulin pumps market. Increasing prevalence of type 1 diabetes, rising diabetic healthcare expenditure, and availability of reimbursement are the factors attributing to the growth of this segment.

On the basis of end user, the insulin delivery devices market is segmented into patients/homecare and hospitals & clinics. In 2016, the patients/homecare segment commanded the largest share of the insulin delivery devices market and is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing diabetic population and rising healthcare expenditure.

In 2016, North America accounted for the largest share of the global insulin delivery devices market. The large share of this segment can be attributed to the rising prevalence of diabetes and favorable reimbursement scenario in the U.S. and Canada, growing venture capital investments and issuance of IPOs in the U.S., and FDA approvals to increase the commercial availability of insulin delivery devices in the U.S.

Note: Product cover images may vary from those shown
5 of 5
  • Animas Corporation (Johnson And Johnson)
  • Becton, Dickinson And Company
  • Biocon Limited
  • Eli Lilly And Company
  • Insulet Corporation
  • Medtronic Plc
  • Novo Nordisk A/S
  • Sanofi
  • Tandem Diabetes Care, Inc.
  • Ypsomed Holding Ag
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll